Mapouka Mexan MD, MPH (@MapoukaMexan) header
Mapouka Mexan MD, MPH (@MapoukaMexan) profile picture

Internal Medicine Resident at the University of Maryland Capital Region Health | Aspiring Gastroenterologist & Hepatologist I Fulbright & Rotary Peace scholar

United States
Joined October 2019
Photo by Mapouka Mexan MD, MPH (@MapoukaMexan)Photo by Mapouka Mexan MD, MPH (@MapoukaMexan)Photo by Mapouka Mexan MD, MPH (@MapoukaMexan)Photo by Mapouka Mexan MD, MPH (@MapoukaMexan)Photo by Mapouka Mexan MD, MPH (@MapoukaMexan)Photo by Mapouka Mexan MD, MPH (@MapoukaMexan)Photo by Mapouka Mexan MD, MPH (@MapoukaMexan)Photo by Mapouka Mexan MD, MPH (@MapoukaMexan)Photo by Mapouka Mexan MD, MPH (@MapoukaMexan)Photo by Mapouka Mexan MD, MPH (@MapoukaMexan)
Feeling grateful to join the group for a morning run in Nashville before today’s ACG sessions! Always a great way to start the day! 🏃🏾‍♂️ Thank you to everyone who showed up! @AmCollegeGastro #DiversityinGIFUnRun #GITweet
2
7
500
There’s no better place to be right now than Nashville, surrounded by our amazing #AAFG community! Our members are ready to shine, with multiple posters, oral presentations, and lectures to share at #ACG2026 #GItwitter @POHER_NGO
6
21
816
I’m grateful and excited to present my work at the ACG on 10/12/2026! Please stop by posters P4073 and P3163 Exhibit Halls A - D (Level 3) @AmCollegeGastro @HealioGastro
4
204
Grateful to share this paper on intersection depression/MASLD: - Among U.S. adults with ACLD: ➡️ ~1 in 7 had comorbid depression ➡️ Women & young adults are particularly vulnerable sciencedirect.com/science/ar… @AASLDtweets @AmerGastroAssn @AGA_GHAdvances @AmCollegeGastro
1
6
183
Mapouka Mexan MD, MPH retweeted
🧠 Sometimes, the most meaningful research questions begin with one patient. A patient with MASLD + unrecognized depression struggling with treatment made me ask: How much depression are we missing in ACLD? That question became a national study now published in @AGA_GHAdvances. Among U.S. adults with ACLD: ➡️ ~1 in 7 had comorbid depression ➡️ Burden increased after the COVID-19 pandemic ➡️ Women & young adults particularly vulnerable Liver care cannot stop at the liver. 📄 doi.org/10.1016/j.gastha.202… #Hepatology #MentalHealth #LiverDisease
3
7
26
857
Mapouka Mexan MD, MPH retweeted
Check out the September issue of GIE: giejournal.org/current #GITwitter
2
3
814
Mapouka Mexan MD, MPH retweeted
🚨 Obesity is reshaping liver transplantation. Our latest study analyzed ~180,000 liver transplant recipients across 3 decades using the @UNOSNews transplant registry. 📆 1988–2022 📈 Mean BMI: 24.7 → 28.9 kg/m² 🔮 Projected BMI by 2050: 30.1 kg/m² Big thanks to @Bubu_Banini and @YaleFattyLiver for the support, as always. 📄 Full paper: mdpi.com/2673-4389/6/4/81
2
7
800
Happy to share our 30-year national cohort study: non-obese patients with MASLD had over a threefold higher risk of Alzheimer’s disease–associated mortality than those with obesity. Grateful for the mentorship, our team, and the opportunity to keep learning about liver disease! @AmerGastroAssn @AASLDtweets @AASLDFoundation @AmCollegeGastro @SarpB44 @basilenjei #GITweet ghadvances.org/article/S2772…
1
2
1,033
Happy to share our newly published retrospective cohort study, in which we examined national trends in chronic pancreatitis hospitalizations across the United States over time!@SarpB44 #GITweet @AmerGastroAssn @AmCollegeGastro #Pancreatitis #Pancreas
3
5
431
Mapouka Mexan MD, MPH retweeted
Thank you, @AAFG_2021 We need to incorporate value-based care in MASH therapeutics @DDWMeeting @basilenjei #medtwitter #gitwitter
How does a resident get a full room to watch them present oral abstract lectures at large GI conferences? Our ⭐ resident @SarpB44 sure knows how. Top presentation on cost effectiveness of Resmetirom vs Semaglutide for non-cirrhotic MASH #GItwitter
1
9
30
1,290